|
⚲
|
| Keyboard |
| Gutfreund John Peter
✚
|
|
|---|---|
| CIK # | 0001940797 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001940797] | |
| 4 | [0001940797] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Oncocyte Corp | |
| Gutfreund John Peter |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oncocyte Corp OCX
Common Stock, no par value
|
2023-06-30 | Other | 3,085,047 | $0.00 | |
|
Oncocyte Corp OCX
Warrants to Purchase Common Stock · derivative
|
2023-06-30 | Other | 3,564,728 | $0.00 | |
|
Oncocyte Corp OCX
Series A Convertible Preferred Stock · derivative
|
2023-04-03 | Disposed to issuer | 588.24 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2023-04-03 | Grant | 1,000,000 | $0.35 | 350,000 |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2023-04-03 | Grant | 705,000 | $0.35 | 246,750 |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-12-23 | Buy | 75,000 | $0.33 | 24,750 |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-08-15 | Grant | 10,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-08-15 | Buy | 25,000 | $0.93 | 23,250 |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2022-08-15 | Grant | 45,000 | $0.00 |